NeuroSense Therapeutics Ltd. (NRSN) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NeuroSense Therapeutics L...

    NASDAQ: NRSN · Real-Time Price · USD
    1.25
    0.02 (1.63%)
    At close: Oct 03, 2025, 3:59 PM
    1.25
    0.00%
    After-hours: Oct 03, 2025, 07:58 PM EDT

    NeuroSense Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -2.19 -1.06 -1.14 -6.61
    PEG Ratio
    		 0.06 0.05 -0.00 0.12
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 8.64 -5.71 2.50 2.97
    P/FCF Ratio
    		 -2.2 -1.28 -1.83 -17.16
    P/OCF Ratio
    		 -2.2 -1.28 -1.85 -17.35
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.03 -0.08 0.04 0.20
    Quick Ratio
    		 2.21 0.84 6.41 19.41
    Current Ratio
    		 2.21 0.84 4.28 19.12
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -31.84 -21.91 -903.47 -4.84
    Return on Equity
    		 -3.95 5.39 -2.2 -0.45
    Return on Assets
    		 -2.23 -3.18 -1.6 -0.35
    Return on Invested Capital
    		 -3.63 88.60 -2.01 -0.32
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist